ScarNa28: A Potential Drug Target and Biomarker (G106633801)

Target Name: SCARNA28

NCBI ID: G106633801

Other Name(s): ZL1 | small Cajal body-specific RNA 28 | Small Cajal body-specific RNA 28

ScarNa28: A Potential Drug Target and Biomarker

SCARNA28 (ZL1) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the SCARNA family of proteins, which are known for their role in intracellular signaling. One of the functions of SCARNA28 is to regulate the activity of the protein p120, which is involved in the detoxification of harmful substances.

Recent studies have suggested that SCARNA28 may have potential as a drug target or biomarker. For example, some researchers have found that inhibiting the activity of SCARNA28 can reduce the formation of neurofibrillary tangles, which are thought to be a hallmark of Alzheimer's disease. Other studies have also shown that SCARNA28 is involved in the regulation of the immune response, which may be relevant to the development of certain autoimmune diseases.

In addition to its potential drug-related applications, SCARNA28 is also of interest as a potential biomarker for certain diseases. For example, some researchers have suggested that SCARNA28 may be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Others have suggested that SCARNA28 may be involved in the development of certain cardiovascular diseases, such as heart failure and hypertension.

Overall, the study of SCARNA28 is an exciting area of research, with potential applications in the development of new treatments for a variety of diseases. Further studies are needed to fully understand its role in these processes and to determine its potential as a drug target or biomarker.

Protein Name: Small Cajal Body-specific RNA 28

More Common Targets

AREAS

Q&A

STOCKS

TARGETS

CONTACT

BD@bio.cacnex.com